{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:17:48Z","timestamp":1793089068453,"version":"4.5.0"},"reference-count":85,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.beem.2011.05.011","type":"journal-article","created":{"date-parts":[[2011,11,22]],"date-time":"2011-11-22T15:32:43Z","timestamp":1321975963000},"page":"885-896","source":"Crossref","is-referenced-by-count":100,"title":["Prolactinoma in pregnancy"],"prefix":"10.1016","volume":"25","author":[{"given":"Mark E.","family":"Molitch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.beem.2011.05.011_bib1","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1210\/jcem-59-5-941","article-title":"Abnormal patterns of pulsatile luteinizing hormone secretion in women with hyperprolactinemia and amenorrhea: responses to bromocriptine","volume":"59","author":"Sauder","year":"1984","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2011.05.011_bib2","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1365-2265.1984.tb03467.x","article-title":"Altered pulsatile secretion of luteinizing hormone in hypogonadal men with hyperprolactinaemia","volume":"21","author":"Winters","year":"1984","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.beem.2011.05.011_bib3","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1210\/jcem-42-1-132","article-title":"Hyperprolactinemic anovulatory syndrome","volume":"42","author":"Bohnet","year":"1976","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2011.05.011_bib4","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1210\/jcem-56-4-774","article-title":"Alpha-subunit and gonadotropin responses to luteinizing hormone-releasing hormone in hyperprolactinemic women before and after bromocriptine","volume":"56","author":"Klibanski","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2011.05.011_bib5","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/0002-9378(77)90246-0","article-title":"Pituitary responses to synthetic luteinizing hormone-releasing hormone in thirty-four cases of amenorrhea or oligomenorrhea associated with galactorrhea","volume":"127","author":"Van Campenhout","year":"1977","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.beem.2011.05.011_bib6","series-title":"The Pituitary Adenoma","first-page":"65","article-title":"Galactorrhea syndromes","author":"Biller","year":"1980"},{"key":"10.1016\/j.beem.2011.05.011_bib7","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1136\/bmj.3.5978.274","article-title":"An abnormality of oestrogen feedback in amenorrhoea-galactorrhoea","volume":"3","author":"Glass","year":"1975","journal-title":"Br Med J"},{"key":"10.1016\/j.beem.2011.05.011_bib8","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1210\/me.13.7.1084","article-title":"Stat5-mediated regulation of the human type II 3beta-hydroxysteroid dehydrogenase\/delta5-delta4 isomerase gene: activation by prolactin","volume":"13","author":"Feltus","year":"1999","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.beem.2011.05.011_bib9","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1073\/pnas.84.9.2643","article-title":"Human pituitary and placental hormones control human insulin-like growth factor II secretion in human granulosa cells","volume":"84","author":"Ramasharma","year":"1987","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.beem.2011.05.011_bib10","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1210\/jcem-54-6-1246","article-title":"Prolactin directly inhibits basal as well as gonadotropin-stimulated secretion of progesterone and 17 beta-estradiol in the human ovary","volume":"54","author":"Demura","year":"1982","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2011.05.011_bib11","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1210\/endo-110-5-1701","article-title":"Antigonadal action of prolactin: further studies on the mechanism of inhibition of follicle-stimulating hormone-induced aromatase activity in rat granulosa cell cultures","volume":"110","author":"Dorrington","year":"1982","journal-title":"Endocrinology"},{"key":"10.1016\/j.beem.2011.05.011_bib12","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1210\/mend-4-1-13","article-title":"Regulation of aromatase mRNA and estradiol biosynthesis in rat ovarian granulosa and luteal cells by prolactin","volume":"4","author":"Krasnow","year":"1990","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.beem.2011.05.011_bib13","first-page":"692","article-title":"Hyperprolactinemia and primary amenorrhea","volume":"54","author":"Kemmann","year":"1979","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.beem.2011.05.011_bib14","first-page":"715","article-title":"Clinical and laboratory evaluation of patients with primary amenorrhea","volume":"57","author":"Mashchak","year":"1981","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.beem.2011.05.011_bib15","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0015-0282(16)45369-0","article-title":"Prolactin and reproduction","volume":"35","author":"Pepperell","year":"1981","journal-title":"Fertil Steril"},{"key":"10.1016\/j.beem.2011.05.011_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0011-5029(82)90628-9","article-title":"Hyperprolactinemic disorders","volume":"28","author":"Molitch","year":"1982","journal-title":"Dis Mon"},{"key":"10.1016\/j.beem.2011.05.011_bib17","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0140-6736(76)91343-X","article-title":"Hyperprolactinaemia and luteal insufficiency","volume":"1","author":"Seppala","year":"1976","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2011.05.011_bib18","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.fertnstert.2009.12.017","article-title":"Prevalence of hyperprolactinemia and abnormal magnetic resonance imaging findings in a population with infertility","volume":"94","author":"Souter","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.beem.2011.05.011_bib19","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/BF02939147","article-title":"Plasma prolactin in amenorrhoea, infertility, and other disorders: a retrospective study of 608 patients","volume":"149","author":"Skrabanek","year":"1980","journal-title":"Ir J Med Sci"},{"key":"10.1016\/j.beem.2011.05.011_bib20","first-page":"651","article-title":"Transient hyperprolactinemia in infertile women with luteal phase deficiency","volume":"78","author":"Huang","year":"1991","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.beem.2011.05.011_bib21","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1365-2265.2006.02562.x","article-title":"Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas","volume":"65","author":"Casanueva","year":"2006","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.beem.2011.05.011_bib22","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1210\/jc.2010-1692","article-title":"Diagnosis and treatment of hyperprolactinemia: an Endocrine Society Clinical Practice Guideline","volume":"96","author":"Melmed","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2011.05.011_bib23","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/BF01727477","article-title":"Bromocriptine in pregnancy: safety aspects","volume":"65","author":"Krupp","year":"1987","journal-title":"Klin Wochenschr"},{"key":"10.1016\/j.beem.2011.05.011_bib24","series-title":"The safety aspects of infertility treatments. Program of the Second World Congress of Gynecology and Obstetrics","author":"Krupp","year":"1988"},{"key":"10.1016\/j.beem.2011.05.011_bib25","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1159\/000180100","article-title":"Follow-up of children born of bromocriptine-treated mothers","volume":"22","author":"Raymond","year":"1985","journal-title":"Horm Res"},{"key":"10.1016\/j.beem.2011.05.011_bib26","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0015-0282(16)45806-1","article-title":"Bromocriptine as prophylactic therapy in prolactinoma during pregnancy","volume":"36","author":"Canales","year":"1981","journal-title":"Fertil Steril"},{"key":"10.1016\/j.beem.2011.05.011_bib27","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/0002-9378(83)90968-7","article-title":"Continuous administration of bromocriptine in the prevention of neurological complications in pregnant women with prolactinomas","volume":"146","author":"Konopka","year":"1983","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.beem.2011.05.011_bib28","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0015-0282(16)47888-X","article-title":"Pregnancy in hyperprolactinemic women","volume":"41","author":"Ruiz-Velasco","year":"1984","journal-title":"Fertil Steril"},{"key":"10.1016\/j.beem.2011.05.011_bib29","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1530\/acta.0.1260489","article-title":"Cabergoline in the long-term therapy of hyperprolactinemic disorders","volume":"126","author":"Ferrari","year":"1992","journal-title":"Acta Endocrinol"},{"key":"10.1016\/j.beem.2011.05.011_bib30","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1056\/NEJM199410063311403","article-title":"For the cabergoline comparative study group. A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. Cabergoline Comparative Study Group","volume":"331","author":"Webster","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beem.2011.05.011_bib31","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/BF03348017","article-title":"Long-term treatment with cabergoline, a new long-lasting ergoline derivative, in\u00a0idiopathic or tumorous hyperprolactinaemia and outcome of drug-induced pregnancy","volume":"20","author":"Ciccarelli","year":"1997","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.beem.2011.05.011_bib32","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/BF03343573","article-title":"Cabegoline: a first-choice treatment in patients with previously untreatd prolactin-secreting pituitary adenoma","volume":"22","author":"Cannav\u00f2","year":"1999","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.beem.2011.05.011_bib33","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1210\/jc.84.7.2518","article-title":"Cabergoline in the treatment of hyperprolactinemia: a study in 455 patients","volume":"84","author":"Verhelst","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2011.05.011_bib34","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0890-6238(02)00055-2","article-title":"Pregnancy outcome after cabergoline treatment in early weeks of gestation","volume":"16","author":"Ricci","year":"2002","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.beem.2011.05.011_bib35","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1023\/A:1022364514971","article-title":"Medical management of pituitary adenomas: the special case of management of the pregnant woman","volume":"5","author":"Bronstein","year":"2002","journal-title":"Pituitary"},{"issue":"Suppl. 1","key":"10.1016\/j.beem.2011.05.011_bib36","first-page":"108","article-title":"Prolactin excess: treatment and toxicity","volume":"2","author":"Gillam","year":"2004","journal-title":"Pediat Endocrinol Rev"},{"key":"10.1016\/j.beem.2011.05.011_bib37","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1093\/humrep\/dem315","article-title":"Implantation is apparently unaffected by the dopamine agonist cabergoline when administered to prevent ovarian hyperstimulation syndrome in women undergoing assisted reproduction treatment: a pilot study","volume":"22","author":"\u00c1lvarez","year":"2007","journal-title":"Human Reprod"},{"key":"10.1016\/j.beem.2011.05.011_bib38","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1365-2265.2007.03000.x","article-title":"Pregnancy outcomes following cabergoline treatment: extended results from a 12-year observational study","volume":"68","author":"Colao","year":"2008","journal-title":"Clin Endocrinol [Oxf]"},{"key":"10.1016\/j.beem.2011.05.011_bib39","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00404-008-0917-8","article-title":"Pregnancy outcome in pituitary adenomas","volume":"280","author":"Sharma","year":"2009","journal-title":"Arch Gynaecol Obstet"},{"key":"10.1016\/j.beem.2011.05.011_bib40","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1210\/jc.2009-2605","article-title":"High-dose cabergoline therapy for hyperprolactinemic infertility in women with micro- and macroprolactinomas","volume":"95","author":"Ono","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2011.05.011_bib41","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1365-2265.2010.03808.x","article-title":"Outcome of 100 pregnancies initiated under treatment with cabergoline in hyperprolactinaemic women","volume":"73","author":"Lebbe","year":"2010","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.beem.2011.05.011_bib42","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s11102-010-0243-6","article-title":"Effects of cabergoline on pregnancy and embryo-fetal development: retrospective study on 103 pregnancies and a review of the literature","volume":"13","author":"Stalldecker","year":"2010","journal-title":"Pituitary"},{"key":"10.1016\/j.beem.2011.05.011_bib43","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/bdra.20294","article-title":"National estimates and race\/ethnic specific variation of selected birth defects in the United States, 1999\u20132001","volume":"76","author":"Canfield","year":"2006","journal-title":"Birth Defects Res (Part A)"},{"key":"10.1016\/j.beem.2011.05.011_bib44","unstructured":"Anon. American Pregnancy Association Statistics. www.americanpregnancy.org\/main\/statistics.html accessed April, 2011."},{"key":"10.1016\/j.beem.2011.05.011_bib45","first-page":"1","article-title":"Births: final data for 2007","volume":"58","author":"Martin","year":"2010","journal-title":"Natl Vital Stat Rep"},{"key":"10.1016\/j.beem.2011.05.011_bib46","doi-asserted-by":"crossref","first-page":"228","DOI":"10.2165\/00002018-199614040-00003","article-title":"A comparative review of the tolerability profiles of dopamine agonists in the treatment of hyperprolactinaemia and inhibition of lactation","volume":"14","author":"Webster","year":"1996","journal-title":"Drug Saf"},{"key":"10.1016\/j.beem.2011.05.011_bib47","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/0002-9378(77)90594-4","article-title":"Pattern of increase in circulating prolactin levels during human gestation","volume":"129","author":"Rigg","year":"1977","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.beem.2011.05.011_bib48","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0002-9378(15)31297-7","article-title":"Factors influencing the secretion of human prolactin and growth hormone in menstrual and gestational women","volume":"116","author":"Tyson","year":"1973","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.beem.2011.05.011_bib49","first-page":"1","article-title":"Circulating prolactin levels. I. normal females","volume":"22","author":"Poindexter","year":"1977","journal-title":"Int J Fertil"},{"key":"10.1016\/j.beem.2011.05.011_bib50","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0025-6196(12)60946-X","article-title":"The pituitary gland in pregnancy: a clinicopathologic and immunohistochemical study of 69 cases","volume":"65","author":"Scheithauer","year":"1990","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.beem.2011.05.011_bib51","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0002-9343(88)80346-2","article-title":"Pituitary gland growth during normal pregnancy: an in\u00a0vivo study using magnetic resonance imaging","volume":"85","author":"Gonzalez","year":"1988","journal-title":"Am J Med"},{"key":"10.1016\/j.beem.2011.05.011_bib52","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1148\/radiology.181.2.1924800","article-title":"Size and shape of the pituitary gland during pregnancy and post partum: measurement with MR imaging","volume":"181","author":"Elster","year":"1991","journal-title":"Radiology"},{"key":"10.1016\/j.beem.2011.05.011_bib53","first-page":"64","article-title":"Pituitary dimensions and volume measurements in pregnancy and post partum. MR assessment","volume":"39","author":"Din\u00e7","year":"1998","journal-title":"Acta Radiol"},{"key":"10.1016\/j.beem.2011.05.011_bib54","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0015-0282(16)43929-4","article-title":"Outcome of pregnancy in women with pituitary adenoma","volume":"31","author":"Gemzell","year":"1979","journal-title":"Fertil Steril"},{"key":"10.1016\/j.beem.2011.05.011_bib55","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1056\/NEJM198505233122106","article-title":"Pregnancy and the hyperprolactinemic woman","volume":"312","author":"Molitch","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beem.2011.05.011_bib56","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1530\/acta.0.1110452","article-title":"Women with prolactinoma \u2013 effect of pregnancy and lactation on serum prolactin and on tumour growth","volume":"111","author":"Holmgren","year":"1986","journal-title":"Acta Endocrinol"},{"key":"10.1016\/j.beem.2011.05.011_bib57","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0028-2243(92)90253-U","article-title":"Outcome and long-term effects of pregnancy in women with hyperprolactinemia","volume":"46","author":"Ampudia","year":"1992","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.beem.2011.05.011_bib58","doi-asserted-by":"crossref","first-page":"473","DOI":"10.7326\/0003-4819-121-7-199410010-00001","article-title":"Visual loss in pregnant women with pituitary adenomas","volume":"121","author":"Kupersmith","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.beem.2011.05.011_bib59","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0301-2115(95)02257-0","article-title":"Outcome of pregnancies in women with treated or untreated hyperprolactinemia","volume":"63","author":"Rossi","year":"1995","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.beem.2011.05.011_bib60","first-page":"306","article-title":"The long-term effects of pregnancy and bromocriptine tratment on prolactinomas \u2013 the value of radiologic studies","volume":"3","author":"Badawy","year":"1997","journal-title":"Early Pregnancy: Biology and Medicine"},{"key":"10.1016\/j.beem.2011.05.011_bib61","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/j.1600-0412.2002.810314.x","article-title":"Pregnancy in hyperprolactinemic women","volume":"81","author":"Mallmann","year":"2002","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.beem.2011.05.011_bib62","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1530\/acta.0.0950412","article-title":"Bromocriptine treatment during early human pregnancy: effect on the levels of prolactin, sex steroids and placental lactogen","volume":"95","author":"Ylikorkala","year":"1980","journal-title":"Acta Endocrinol"},{"key":"10.1016\/j.beem.2011.05.011_bib63","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/BF03350411","article-title":"Influence of bromocriptine on plasma levels of prolactin and steroid hormones in the 20th week of pregnancy","volume":"2","author":"Lehmann","year":"1979","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.beem.2011.05.011_bib64","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0140-6736(77)90937-0","article-title":"Pregnancy and delivery under bromocriptine therapy","volume":"2","author":"Espersen","year":"1977","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2011.05.011_bib65","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ijgo.2007.04.027","article-title":"Cabergoline treatment of pregnant women with macroprolactinomas","volume":"99","author":"Laloi-Michelin","year":"2007","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.beem.2011.05.011_bib66","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1023\/A:1015319007880","article-title":"Successful treatment of a large macroprolactinoma with cabergoline during pregnancy","volume":"4","author":"Liu","year":"2001","journal-title":"Pituitary"},{"key":"10.1016\/j.beem.2011.05.011_bib67","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/j.1365-2265.2008.03425.x","article-title":"High dose cabergoline therapy for a resistant macroprolactinoma during pregnancy","volume":"70","author":"Banerjee","year":"2009","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.beem.2011.05.011_bib68","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1093\/oxfordjournals.humrep.a137010","article-title":"Is pregnancy the best treatment for hyperprolactinaemia?","volume":"4","author":"Crosignani","year":"1989","journal-title":"Hum Reprod"},{"key":"10.1016\/j.beem.2011.05.011_bib69","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/0002-9378(86)90164-X","article-title":"Pregnancy after treatment in patients with prolactinoma: operation versus bromocriptine","volume":"155","author":"Samaan","year":"1986","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.beem.2011.05.011_bib70","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0015-0282(16)59182-1","article-title":"Relationship between the methods of treatment for prolactinomas and the puerperal lactation","volume":"47","author":"Ikegami","year":"1987","journal-title":"Fertil Steril"},{"key":"10.1016\/j.beem.2011.05.011_bib71","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1210\/er.2005-9998","article-title":"Advances in the treatment of prolactinomas","volume":"27","author":"Gillam","year":"2006","journal-title":"Endocrine Revs"},{"key":"10.1016\/j.beem.2011.05.011_bib72","doi-asserted-by":"crossref","first-page":"685","DOI":"10.3171\/jns.1983.58.5.0685","article-title":"Pregnancy following transsphenoidal resection of prolactin-secreting pituitary tumors","volume":"58","author":"Laws","year":"1983","journal-title":"J Neurosurg"},{"key":"10.1016\/j.beem.2011.05.011_bib73","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1471-0528.1978.tb14949.x","article-title":"Induction of ovulation with clomiphene and human chorionic gonadotrophin in women with hyperprolactinaemic amenorrhoea","volume":"85","author":"McGarrigle","year":"1978","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.beem.2011.05.011_bib74","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0015-0282(16)44178-6","article-title":"Induction of ovulation in women with hyperprolactinemic amenorrhea using clomiphene and human chorionic gonadotropin or bromocriptine","volume":"32","author":"Radwanska","year":"1979","journal-title":"Fertil Steril"},{"key":"10.1016\/j.beem.2011.05.011_bib75","first-page":"145","article-title":"Hypopituitarism following external radiotherapy for pituitary tumours in adults","volume":"70","author":"Littley","year":"1989","journal-title":"Q J Med"},{"key":"10.1016\/j.beem.2011.05.011_bib76","first-page":"758","article-title":"Relationship between maternal prolactin levels during pregnancy and lactation in women with pituitary adenoma","volume":"37","author":"Narita","year":"1985","journal-title":"Nippon Sanka Fujinka Gakkai Zasshi"},{"key":"10.1016\/j.beem.2011.05.011_bib77","first-page":"425","article-title":"Prolactin-producing microadenomas in pregnancy","volume":"62","author":"Divers","year":"1983","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.beem.2011.05.011_bib78","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.mri.2004.01.047","article-title":"Absence of harmful effects of magnetic resonance exposure at 1.5\u00a0T in utero during the third trimester of pregnancy: a follow-up study","volume":"22","author":"Kok","year":"2004","journal-title":"Magnet Res Imaging"},{"key":"10.1016\/j.beem.2011.05.011_bib79","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.pbiomolbio.2004.08.010","article-title":"A review of the current use of magnetic resonance imaging in pregnancy and safety implications for the fetus","volume":"87","author":"DeWilde","year":"2005","journal-title":"Prog Biophys Mol Biol"},{"key":"10.1016\/j.beem.2011.05.011_bib80","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1007\/s00330-004-2583-y","article-title":"The use of iodinated and gadolinium contrast media during pregnancy and lactation","volume":"15","author":"Webb","year":"2005","journal-title":"Eur Radiol"},{"key":"10.1016\/j.beem.2011.05.011_bib81","first-page":"309","article-title":"Safety of gadolinium during pregnancy","volume":"52","author":"Garcia-Bournissen","year":"2006","journal-title":"Can Fam Phys"},{"key":"10.1016\/j.beem.2011.05.011_bib82","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1365-2265.1986.tb01698.x","article-title":"Failure of prophylactic surgery to avert massive pituitary expansion in pregnancy","volume":"25","author":"Belchetz","year":"1986","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.beem.2011.05.011_bib83","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S0002-9378(16)32785-5","article-title":"Surgery during pregnancy and fetal outcome","volume":"138","author":"Brodsky","year":"1980","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.beem.2011.05.011_bib84","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.amjsurg.2005.03.033","article-title":"Pregnancy outcome following non-obstetric surgical intervention","volume":"190","author":"Cohen-Kerem","year":"2005","journal-title":"Am J Surg"},{"key":"10.1016\/j.beem.2011.05.011_bib85","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0889-8529(05)70061-X","article-title":"Medical treatment of prolactinomas","volume":"28","author":"Molitch","year":"1999","journal-title":"Endocrinol Metab Clin North Am"}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X11000649?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X11000649?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,14]],"date-time":"2024-04-14T19:27:41Z","timestamp":1713122861000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X11000649"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":85,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S1521690X11000649"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2011.05.011","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}